Intelligent Bio Solutions (INBS) is a promising small-cap biotech company with a novel fingerprint drug testing technology, strong revenue growth, and a significant market opportunity, making it a potential buy.
Source Post
The thirty-billion-dollar safety screening industry is currently facing a massive identity crisis because t...
Road to 100k PortfolioMay 12, 2026
This reel highlights Intelligent Bio Solutions (INBS), a small-cap biotech company focused on revolutionizing drug testing with a portable, rapid fingerprint-based scanner. The video discusses the limitations of traditional drug testing methods and presents INBS's technology as a faster, cheaper, and more practical alternative, citing strong revenue growth and market opportunity.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
INBS
buy opened May 12, 2026
-20.13%